Apellis Pharmaceuticals Inc Stock Performance
as on March 25, 2026 at 6:59 am IST
Day's Low
Day's High
$16.84$17.45
2.21%
Downside
1.34%
Upside
52 Week's Low
52 Week's High
$16.10$30.486.50%
Downside
77.00%
Upside
Apellis Pharmaceuticals Inc share price movements today
- Previous Close
- $17.57
- Open
- $17.22
- Volume
- 1.5M
- Day's Low - High
- $16.84 - $17.45
- 52 Week Low - High
- $16.10 - $30.48
Apellis Pharmaceuticals Inc Historical Returns
- 1 Month Return
- -17.97 %
- 3 Month Return
- -30.17 %
- 1 Year Return
- -26.05 %
- 3 Year Return
- -72.12 %
- 5 Year Return
- -57.31 %
Apellis Pharmaceuticals Inc Stock Fundamentals & Key Indicators
Check Apellis Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.2B
EPS (TTM)
-1.2188
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
97.61
Industry PE ratio
7.867522123893806
PEG Ratio
0EBITDA
57.0M
Revenue (TTM)
1.0B
Profit Margin
2.23%
Return On Equity TTM
7.48%
Apellis Pharmaceuticals Inc Stock Valuation
Track how Apellis Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Apellis Pharmaceuticals Inc in the last 5 years
Lowest (-20.71x)
December 31, 2024
Industry (7.87x)
March 25, 2026
Today (97.61x)
March 25, 2026
Highest (180.48x)
December 31, 2025
Today’s Price to Earnings Ratio: 97.61x
Apellis Pharmaceuticals Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Apellis Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.2B | -57.31% | 97.61 | 2.23% | |
| BUY | $41.4B | 126.75% | 133.41 | 8.45% | |
| BUY | $115.3B | 112.49% | 29.68 | 32.94% | |
| NA | $31.6B | NA | 111 | 5.37% | |
| BUY | $77.5B | 58.91% | 17.67 | 31.41% |
Stock Returns calculator for Apellis Pharmaceuticals Inc Stock including INR - Dollar returns
The Apellis Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Apellis Pharmaceuticals Inc investment value today
Current value as on today
₹82,015
Returns
Returns from Apellis Pharmaceuticals Inc Stock
Dollar Returns*
₹9,541 (+9.54%)
Analyst Recommendation on Apellis Pharmaceuticals Inc Stock
Based on 23 analysts
82.61%
Buy
17.39%
Hold
0.00%
Sell
Based on 23 analysts, 82.61% of analysts recommend a 'BUY' rating for Apellis Pharmaceuticals Inc. Average target price of $33.4
Apellis Pharmaceuticals Inc Share Price Target
Get share price movements and forecasts by analysts on Apellis Pharmaceuticals Inc.
What analysts predicted
48.44%UPSIDE
Target Price
$33.4
Current Price
$17.22
Analyzed by
23 Analysts
Target
$33.40
Apellis Pharmaceuticals Inc target price $33.4, a slight upside of 48.44% compared to current price of $17.22. According to 23 analysts rating.
Apellis Pharmaceuticals Inc Stock’s Investor Sentiment and Interest
Search interest for Apellis Pharmaceuticals Inc Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Apellis Pharmaceuticals Inc Quarterly Profit & Loss
All numbers in Millions USD
Apellis Pharmaceuticals Inc Annual Profit & Loss
All numbers in Millions USD
Apellis Pharmaceuticals Inc Quarterly Cash Flow
All numbers in Millions USD
Apellis Pharmaceuticals Inc Annual Cash Flow
All numbers in Millions USD
Insights on Apellis Pharmaceuticals Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 42.2%
- NO EFFECT
Against Peers
In the last 3 years, Apellis Pharmaceuticals Inc has experienced a drawdown of -72.1%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 61.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 215.71M → -58.95M (in $), with an average decrease of 127.3% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 458.57M → 199.91M (in $), with an average decrease of 56.4% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, APLS stock has moved down by -18.0%
About Apellis Pharmaceuticals Inc
| Organisation | Apellis Pharmaceuticals Inc |
| Headquarters | 100 Fifth Avenue, Waltham, MA, United States, 02451 |
| Industry | Distribution Services |
| CEO | Dr. Cedric Francois M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Apellis Pharmaceuticals Inc
Name | Title |
|---|---|
Mr. Timothy E. Sullivan | CFO & Treasurer |
Dr. Caroline R. Baumal M.D. | Chief Medical Officer |
Dr. Pascal Deschatelets Ph.D. | Co-Founder & Chief Scientific Officer |
Dr. Cedric Francois M.D., Ph.D. | Co-Founder, President, CEO & Director |
Mr. Alec Machiels J.D., MBA | Co-Founder & Director |
Mr. David O. Watson Esq., J.D. | General Counsel & Secretary |
Mr. James G. Chopas CPA | VP, Corporate Controller & Chief Accounting Officer |
Ms. Eva Stroynowski | Head of Investor Relations |
Ms. Kelley Boucher | Chief People Officer |
Prof. Peter Hillmen M.D., Ph.D. | Head of Hematology Engagement & Member of PNH Scientific Advisory Board |
FAQs
What is Apellis Pharmaceuticals Inc share price today?
Apellis Pharmaceuticals Inc share price today is $17.22 as on at the close of the market. Apellis Pharmaceuticals Inc share today touched a day high of $17.45 and a low of $16.84.
What is the 52 week high and 52 week low for Apellis Pharmaceuticals Inc share?
Apellis Pharmaceuticals Inc share touched a 52 week high of $30.48 on and a 52 week low of $16.1 on . Apellis Pharmaceuticals Inc stock price today i.e. is closed at $17.22,which is 43.50% down from its 52 week high and 6.96% up from its 52 week low.
What is Apellis Pharmaceuticals Inc's market capitalisation today?
Apellis Pharmaceuticals Inc market capitalisation is $0.00T as on .
How to invest in Apellis Pharmaceuticals Inc Stock (APLS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Apellis Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apellis Pharmaceuticals Inc Shares that will get you 0.0871 shares as per Apellis Pharmaceuticals Inc share price of $17.22 per share as on March 25, 2026 at 1:29 am IST.
What is the minimum amount required to buy Apellis Pharmaceuticals Inc Stock (APLS) from India?
Indian investors can start investing in Apellis Pharmaceuticals Inc (APLS) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Apellis Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Apellis Pharmaceuticals Inc share’s latest price of $17.22 as on March 25, 2026 at 1:29 am IST, you will get 0.5807 shares of Apellis Pharmaceuticals Inc. Learn more about
fractional shares .
What are the returns that Apellis Pharmaceuticals Inc has given to Indian investors in the last 5 years?
Apellis Pharmaceuticals Inc stock has given -57.31% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?